CMC Alternating with VAP Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of high-dose cyclophosphamide, methotrexate, and lomustine (CMC) alternating with vincristine, doxorubicin, and procarbazine (VAP) that may be used in the treatment of small cell lung cancer (SCLC).

**Synonyms:** - CMC-VAP - CMC-VAP - CMC-VAP Regimen - Cyclophosphamide-Methotrexate-CCNU Alternating With Vincristine-Adriamycin-Procarbazine - Cyclophosphamide/Methotrexate/CCNU Alternating With Vincristine/Adriamycin/Procarbazine - Cyclophosphamide/Methotrexate/Lomustine Alternating with Vincristine/Doxorubicin/Procarbazine